首页 > 最新文献

Avicenna Journal of Phytomedicine最新文献

英文 中文
Naringenin modifies T-helper responses and macrophage activities in BALB/c mice. 柚皮苷可改变 BALB/c 小鼠的 T 辅助反应和巨噬细胞活性。
IF 1.9 Q3 CHEMISTRY, MEDICINAL Pub Date : 2024-05-01 DOI: 10.22038/AJP.2023.23382
Fatemeh Keivan, Seyyed Meysam Abtahi Froushani

Objective: Naringenin is a naturally occurring flavonoid found in citrus fruits. This study was done to compare the oral immunomodulatory effects of naringenin and prednisolone.

Materials and methods: The effect of one-month oral administration of naringenin (10, 20, and 40 mg/kg) and prednisolone (2 mg/kg) on peritoneal macrophage was compared in the first set of experiments. Separate evaluations were conducted on the effects of naringenin on in vivo and ex vivoT-helper (Th) lymphocyte responses and their subsets in mice immunized with ovalbumin (OVA). Animals challenged with OVA received oral doses of naringenin or prednisolone from two days prior to immunization to 28 days after immunization.

Results: Naringenin and prednisolone increased macrophages' respiratory burst, and nitric oxide and interleukin (IL)-10 production while decreasing IL-12 production. Macrophages isolated from mice administered with 40 mg/kg naringenin had greater phagocytic potential than those isolated from mice administered with prednisolone. OVA-challenged mice treated with 40 mg/kg naringenin or prednisolone had decreased delayed-type hypersensitivity comparable to control mice. The splenocyte proliferation index was lower in the prednisolone-treated group than the naringenin-treated group, even at 40 mg/kg. In the splenocyte cultures, both agents decreased T-bet expression. Naringenin, in contrast to prednisolone, did not affect GATA3expression. The 40 mg/kg naringenin dose reduced RORγt more effectively than prednisolone.

Conclusion: All these findings indicate the potential of naringenin as a modifying agent of immune responses. Consequently, naringenin may be beneficial in controlling some immunopathological conditions.

目的柚皮苷是一种存在于柑橘类水果中的天然类黄酮。本研究旨在比较柚皮素和泼尼松龙的口服免疫调节作用:第一组实验比较了口服一个月柚皮苷(10、20 和 40 毫克/千克)和泼尼松龙(2 毫克/千克)对腹膜巨噬细胞的影响。我们还分别评估了柚皮素对卵清蛋白(OVA)免疫小鼠体内和体外T-辅助(Th)淋巴细胞反应及其亚群的影响。从免疫前两天到免疫后 28 天,接受 OVA 挑战的动物口服柚皮素或泼尼松龙:结果:柚皮素和泼尼松龙增加了巨噬细胞的呼吸爆发、一氧化氮和白细胞介素(IL)-10的产生,同时降低了IL-12的产生。从服用 40 毫克/千克柚皮苷的小鼠体内分离出的巨噬细胞比从服用泼尼松龙的小鼠体内分离出的巨噬细胞具有更强的吞噬能力。经 40 毫克/千克柚皮苷或泼尼松龙治疗的 OVA 攻击小鼠的迟发型超敏反应下降程度与对照组小鼠相当。泼尼松龙处理组的脾细胞增殖指数低于柚皮素处理组,即使泼尼松龙的剂量为 40 毫克/千克。在脾细胞培养物中,两种药物都能降低 T-bet 的表达。与泼尼松龙相比,柚皮素不影响 GATA3 的表达。与泼尼松龙相比,柚皮苷 40 毫克/千克的剂量能更有效地减少 RORγt 的表达:所有这些发现都表明柚皮甙具有调节免疫反应的潜力。因此,柚皮苷可能有助于控制某些免疫病理状况。
{"title":"Naringenin modifies T-helper responses and macrophage activities in BALB/c mice.","authors":"Fatemeh Keivan, Seyyed Meysam Abtahi Froushani","doi":"10.22038/AJP.2023.23382","DOIUrl":"10.22038/AJP.2023.23382","url":null,"abstract":"<p><strong>Objective: </strong>Naringenin is a naturally occurring flavonoid found in citrus fruits. This study was done to compare the oral immunomodulatory effects of naringenin and prednisolone.</p><p><strong>Materials and methods: </strong>The effect of one-month oral administration of naringenin (10, 20, and 40 mg/kg) and prednisolone (2 mg/kg) on peritoneal macrophage was compared in the first set of experiments. Separate evaluations were conducted on the effects of naringenin on <i>in vivo</i> and <i>ex vivo</i>T-helper (T<sub>h</sub>) lymphocyte responses and their subsets in mice immunized with ovalbumin (OVA). Animals challenged with OVA received oral doses of naringenin or prednisolone from two days prior to immunization to 28 days after immunization.</p><p><strong>Results: </strong>Naringenin and prednisolone increased macrophages' respiratory burst, and nitric oxide and interleukin (IL)-10 production while decreasing IL-12 production. Macrophages isolated from mice administered with 40 mg/kg naringenin had greater phagocytic potential than those isolated from mice administered with prednisolone. OVA-challenged mice treated with 40 mg/kg naringenin or prednisolone had decreased delayed-type hypersensitivity comparable to control mice. The splenocyte proliferation index was lower in the prednisolone-treated group than the naringenin-treated group, even at 40 mg/kg. In the splenocyte cultures, both agents decreased <i>T-bet</i> expression. Naringenin, in contrast to prednisolone, did not affect <i>GATA3</i>expression. The 40 mg/kg naringenin dose reduced <i>RORγt</i> more effectively than prednisolone.</p><p><strong>Conclusion: </strong>All these findings indicate the potential of naringenin as a modifying agent of immune responses. Consequently, naringenin may be beneficial in controlling some immunopathological conditions.</p>","PeriodicalId":8677,"journal":{"name":"Avicenna Journal of Phytomedicine","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11287029/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141858939","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Auraptene inhibits migration, invasion and metastatic behavior of human malignant glioblastoma cells: An in vitro and in silico study. 金合欢烯能抑制人类恶性胶质母细胞瘤细胞的迁移、侵袭和转移行为:一项体外和硅学研究。
IF 1.9 Q3 CHEMISTRY, MEDICINAL Pub Date : 2024-05-01 DOI: 10.22038/AJP.2023.23586
Seyed Hadi Mousavi, Mohammad Jalili-Nik, Mohammad Soukhtanloo, Arash Soltani, Farzaneh Abbasinezhad-Moud, Hamid Mollazadeh, Farzaneh Shakeri, Bahram Bibak, Amirhossein Sahebkar, Amir R Afshari

Objective: The present work examined the anti-metastatic effects of auraptene and their underlying mechanisms of action in U87 Glioblastoma multiforme (GBM) cells.

Materials and methods: To test the hypothesis, cell culture, Matrigel invasion assay, scratch wound healing assay, gelatin zymography assay, qRT-PCR, and western blot experiments were conducted.

Results: At sublethal concentrations of 12.5 and 25 µg/ml, auraptene exhibited a significant reduction in cell invasion and migration of U87 cells, as assessed using scratch wound healing and Transwell tests, respectively. The qRT-PCR and zymography experiments demonstrated a significant decrease in both mRNA expression and activities of MMP-2 and MMP-9 following auraptene treatment. Western blot analysis also showed that MMP-2 protein level and phosphorylation of metastasis-related proteins (p-JNK and p-mTOR) decreased in auraptene-treated cells. Molecular docking studies consistently demonstrated that auraptene exhibits a significant affinity towards MMP-2/-9, the ATP binding site of mTOR and JNK1/2/3.

Conclusion: Auraptene inhibited the migration and invasion of GBM cells. This inhibitory effect was induced by modulating specific mechanisms, including suppressing MMPs, JNK, and mTOR activities.

目的:本研究探讨了痩素对 U87 多形性胶质母细胞瘤细胞的抗转移作用及其作用机制:本研究探讨了金合欢苷在 U87 多形性胶质母细胞瘤(GBM)细胞中的抗转移作用及其作用机制:为验证假设,进行了细胞培养、Matrigel侵袭试验、划痕伤口愈合试验、明胶酶谱分析、qRT-PCR和Western印迹实验:结果:在 12.5 和 25 µg/ml 的亚致死浓度下,金合欢烯能显著减少 U87 细胞的侵袭和迁移,分别通过划痕伤口愈合试验和 Transwell 试验进行评估。qRT-PCR 和酶谱分析实验表明,枳椇烯处理后,MMP-2 和 MMP-9 的 mRNA 表达和活性均显著下降。Western 印迹分析也显示,枳椇树素处理的细胞中 MMP-2 蛋白水平和转移相关蛋白(p-JNK 和 p-mTOR)的磷酸化程度均有所下降。分子对接研究一致表明,枳椇烯对 MMP-2/-9、mTOR 的 ATP 结合位点和 JNK1/2/3 具有显著的亲和力:结论:金萝庚烯可抑制GBM细胞的迁移和侵袭。这种抑制作用是通过调节特定机制(包括抑制 MMPs、JNK 和 mTOR 活性)而产生的。
{"title":"Auraptene inhibits migration, invasion and metastatic behavior of human malignant glioblastoma cells: An <i>in vitro</i> and <i>in silico</i> study.","authors":"Seyed Hadi Mousavi, Mohammad Jalili-Nik, Mohammad Soukhtanloo, Arash Soltani, Farzaneh Abbasinezhad-Moud, Hamid Mollazadeh, Farzaneh Shakeri, Bahram Bibak, Amirhossein Sahebkar, Amir R Afshari","doi":"10.22038/AJP.2023.23586","DOIUrl":"10.22038/AJP.2023.23586","url":null,"abstract":"<p><strong>Objective: </strong>The present work examined the anti-metastatic effects of auraptene and their underlying mechanisms of action in U87 Glioblastoma multiforme (GBM) cells.</p><p><strong>Materials and methods: </strong>To test the hypothesis, cell culture, Matrigel invasion assay, scratch wound healing assay, gelatin zymography assay, qRT-PCR, and western blot experiments were conducted.</p><p><strong>Results: </strong>At sublethal concentrations of 12.5 and 25 µg/ml, auraptene exhibited a significant reduction in cell invasion and migration of U87 cells, as assessed using scratch wound healing and Transwell tests, respectively. The qRT-PCR and zymography experiments demonstrated a significant decrease in both mRNA expression and activities of MMP-2 and MMP-9 following auraptene treatment. Western blot analysis also showed that MMP-2 protein level and phosphorylation of metastasis-related proteins (p-JNK and p-mTOR) decreased in auraptene-treated cells. Molecular docking studies consistently demonstrated that auraptene exhibits a significant affinity towards MMP-2/-9, the ATP binding site of mTOR and JNK1/2/3.</p><p><strong>Conclusion: </strong>Auraptene inhibited the migration and invasion of GBM cells. This inhibitory effect was induced by modulating specific mechanisms, including suppressing MMPs, JNK, and mTOR activities.</p>","PeriodicalId":8677,"journal":{"name":"Avicenna Journal of Phytomedicine","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11287035/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141858858","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A preliminary report comparing the effect of Asafoetida with oral contraceptive on polycystic ovarian syndrome in a double-blind randomized trial. 在一项双盲随机试验中,初步报告比较了 Asafoetida 和口服避孕药对多囊卵巢综合症的影响。
IF 1.9 Q3 CHEMISTRY, MEDICINAL Pub Date : 2024-05-01 DOI: 10.22038/AJP.2023.23122
Najmeh Dehparvar, Ahia Garshasbi, Amir Niasari-Naslaji, Fatemeh Alijaniha, Mohammad Gholami-Fesharaki, Farzaneh Ghaffari, Mohsen Naseri

Objective: Polycystic ovarian syndrome (PCOS) is the most common cause of infertility and endocrine disorders in women of childbearing age. In Persian medicine, Ferula assafoetida L. (Asafoetida) was recommended for treating PCOS. The present study was conducted to compare the effect of Asafoetida with oral contraceptive tablets on PCOS patients.

Materials and methods: Patients with PCOS (n=30) were enrolled in a double-blind randomized clinical trial. On Day 5 of the menstrual cycle, patients received two periods of 21-day treatment, with 7 days rest between the two treatments. On a daily basis, half of the patients (n=15) received Asafoetida (1 g), and the rest received low dose oral contraceptive (LD; one tablet). Menstrual status, anthropometric characteristics, hematology and biochemistry parameters, ovarian ultrasound examination and hirsutism were evaluated prior to the initiation of the experiment and 14 days after the end of treatment. The occurrence of menstrual cycles and pregnancy was assessed eight months after the end of treatment.

Results: The incidence of pregnancy was greater in patients who received Asafoetida compared to those who received LD (p=0.019). The time intervals between menstrual cycles became shorter in both groups (p<0.05). The occurrence of regular menstrual cycles remained longer in the Asafoetida compared to the LD group (p=0.001). Concentrations of triglycerides, cholesterol, HDL and LDL were significantly increased after treating with LD (p<0.05).

Conclusion: In PCOS patients, the occurrence of regular menstrual cycles and the incidence of pregnancy were improved following treatment with Asafoetida. This medicament could be considered a safe treatment for patients with PCOS.

目的:多囊卵巢综合征(PCOS多囊卵巢综合症(PCOS)是导致育龄妇女不孕和内分泌失调的最常见原因。在波斯医学中,阿魏(Asafoetida)被推荐用于治疗多囊卵巢综合征。本研究旨在比较 Asafoetida 与口服避孕药片对多囊卵巢综合征患者的影响:多囊卵巢综合征患者(30 人)被纳入双盲随机临床试验。在月经周期的第 5 天,患者接受两次为期 21 天的治疗,两次治疗之间休息 7 天。每天,半数患者(15 人)服用阿沙弗他片(1 克),其余患者服用低剂量口服避孕药(LD;一片)。在实验开始前和治疗结束后 14 天,对患者的月经状况、人体测量特征、血液学和生物化学参数、卵巢超声波检查和多毛症进行了评估。治疗结束 8 个月后,对月经周期和怀孕情况进行了评估:结果:与接受 LD 治疗的患者相比,接受 Asafoetida 治疗的患者的怀孕率更高(P=0.019)。两组患者的月经周期间隔时间都变短了(P结论:多囊卵巢综合症患者在接受 Asafoetida 治疗后,月经周期规律的发生率和怀孕率都有所提高。这种药物对多囊卵巢综合症患者来说是一种安全的治疗方法。
{"title":"A preliminary report comparing the effect of Asafoetida with oral contraceptive on polycystic ovarian syndrome in a double-blind randomized trial.","authors":"Najmeh Dehparvar, Ahia Garshasbi, Amir Niasari-Naslaji, Fatemeh Alijaniha, Mohammad Gholami-Fesharaki, Farzaneh Ghaffari, Mohsen Naseri","doi":"10.22038/AJP.2023.23122","DOIUrl":"10.22038/AJP.2023.23122","url":null,"abstract":"<p><strong>Objective: </strong>Polycystic ovarian syndrome (PCOS) is the most common cause of infertility and endocrine disorders in women of childbearing age. In Persian medicine, <i>Ferula assafoetida</i> L. (Asafoetida) was recommended for treating PCOS. The present study was conducted to compare the effect of Asafoetida with oral contraceptive tablets on PCOS patients.</p><p><strong>Materials and methods: </strong>Patients with PCOS (n=30) were enrolled in a double-blind randomized clinical trial. On Day 5 of the menstrual cycle, patients received two periods of 21-day treatment, with 7 days rest between the two treatments. On a daily basis, half of the patients (n=15) received Asafoetida (1 g), and the rest received low dose oral contraceptive (LD; one tablet). Menstrual status, anthropometric characteristics, hematology and biochemistry parameters, ovarian ultrasound examination and hirsutism were evaluated prior to the initiation of the experiment and 14 days after the end of treatment. The occurrence of menstrual cycles and pregnancy was assessed eight months after the end of treatment.</p><p><strong>Results: </strong>The incidence of pregnancy was greater in patients who received Asafoetida compared to those who received LD (p=0.019). The time intervals between menstrual cycles became shorter in both groups (p<0.05). The occurrence of regular menstrual cycles remained longer in the Asafoetida compared to the LD group (p=0.001). Concentrations of triglycerides, cholesterol, HDL and LDL were significantly increased after treating with LD (p<0.05).</p><p><strong>Conclusion: </strong>In PCOS patients, the occurrence of regular menstrual cycles and the incidence of pregnancy were improved following treatment with Asafoetida. This medicament could be considered a safe treatment for patients with PCOS.</p>","PeriodicalId":8677,"journal":{"name":"Avicenna Journal of Phytomedicine","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11287033/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141858857","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The therapeutic potential of Wild Bitter Melon to ameliorate muscle atrophy in a murine model. 野生苦瓜在小鼠模型中改善肌肉萎缩的治疗潜力。
IF 1.9 Q3 CHEMISTRY, MEDICINAL Pub Date : 2024-05-01 DOI: 10.22038/AJP.2024.24011
Sima Seifi, Seyedeh Elnaz Nazari, Amir Avan, Nima Khalili-Tanha, Fatemeh Babaei, Saman Soleimanpour, Fereshteh Asgharzadeh, Mousa-Al-Reza Hajzadeh, Majid Khazaei, Abdoljalal Marjani

Objective: Muscle atrophy due to immobility is a common complication of many diseases and a consequence of therapeutic processes. Immobility and inactivity have been shown to be associated with increased inflammation. The aim of this study was to investigate the therapeutic potential of Wild Bitter Melon (WBM) (Momordica charantia Linn) on muscle atrophy due to immobility in a mouse model.

Materials and methods: This study was performed in two phases of atrophy and recovery on male BALB/c mice which were divided into 3 groups: control, immobilized, and experimental. The treatment period with WBM at a dose of 400 mg/kg daily by gavage was 17 days, including 7 days of being immobilized and 10 days of recovery. At the end of each phase, half of the mice from each group were examined regarding the four limb grip strength, and then histological and biochemical analyses were done.

Results: The tissue level of malondialdehyde (MDA) oxidative stress index in the atrophy phase in the atrophy group (5.4567±0.522) nmol/g compared to the control group (3.455±0.065) nmol significantly (p 0.001) <) increased. Also, the tissue level of MDA in the WBM group (3.87±0.035) showed a significant decrease compared to the atrophy group (p<0.01). The strength percentage of four limbs in the mice of the treatment group (-23.46±2.45) was significantly higher than that of the atrophy group (-30.60±3.15) at the end of the atrophy phase.

Conclusion: The results suggest that the use of WBM reduces the degree of inflammation, oxidative stress and muscle damage, as well as muscle atrophy, which may improve the muscle atrophy in mice.

目的:肌肉萎缩是许多疾病的常见并发症,也是治疗过程的一个结果。不动和不活动已被证明与炎症加剧有关。本研究的目的是调查野生苦瓜(WBM)(Momordica charantia Linn)对小鼠模型中因静止不动导致的肌肉萎缩的治疗潜力:本研究以雄性 BALB/c 小鼠为研究对象,分为对照组、固定组和实验组,分萎缩和恢复两个阶段进行。每天灌胃 400 毫克/千克剂量的 WBM 治疗期为 17 天,其中包括 7 天的固定期和 10 天的恢复期。每个阶段结束时,对每组一半的小鼠进行四肢握力检查,然后进行组织学和生化分析:结果:萎缩组萎缩期组织丙二醛(MDA)氧化应激指数水平(5.4567±0.522)nmol/g与对照组(3.455±0.065)nmol相比有显著性差异(P 0.001):结果表明,使用 WBM 可降低炎症、氧化应激和肌肉损伤程度以及肌肉萎缩程度,从而改善小鼠的肌肉萎缩状况。
{"title":"The therapeutic potential of Wild Bitter Melon to ameliorate muscle atrophy in a murine model.","authors":"Sima Seifi, Seyedeh Elnaz Nazari, Amir Avan, Nima Khalili-Tanha, Fatemeh Babaei, Saman Soleimanpour, Fereshteh Asgharzadeh, Mousa-Al-Reza Hajzadeh, Majid Khazaei, Abdoljalal Marjani","doi":"10.22038/AJP.2024.24011","DOIUrl":"10.22038/AJP.2024.24011","url":null,"abstract":"<p><strong>Objective: </strong>Muscle atrophy due to immobility is a common complication of many diseases and a consequence of therapeutic processes. Immobility and inactivity have been shown to be associated with increased inflammation. The aim of this study was to investigate the therapeutic potential of Wild Bitter Melon (WBM) (Momordica charantia Linn) on muscle atrophy due to immobility in a mouse model.</p><p><strong>Materials and methods: </strong>This study was performed in two phases of atrophy and recovery on male BALB/c mice which were divided into 3 groups: control, immobilized, and experimental. The treatment period with WBM at a dose of 400 mg/kg daily by gavage was 17 days, including 7 days of being immobilized and 10 days of recovery. At the end of each phase, half of the mice from each group were examined regarding the four limb grip strength, and then histological and biochemical analyses were done.</p><p><strong>Results: </strong>The tissue level of malondialdehyde (MDA) oxidative stress index in the atrophy phase in the atrophy group (5.4567±0.522) nmol/g compared to the control group (3.455±0.065) nmol significantly (p 0.001) <) increased. Also, the tissue level of MDA in the WBM group (3.87±0.035) showed a significant decrease compared to the atrophy group (p<0.01). The strength percentage of four limbs in the mice of the treatment group (-23.46±2.45) was significantly higher than that of the atrophy group (-30.60±3.15) at the end of the atrophy phase.</p><p><strong>Conclusion: </strong>The results suggest that the use of WBM reduces the degree of inflammation, oxidative stress and muscle damage, as well as muscle atrophy, which may improve the muscle atrophy in mice.</p>","PeriodicalId":8677,"journal":{"name":"Avicenna Journal of Phytomedicine","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11287028/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141858942","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Therapeutic potency of curcumin on radiodermatitis: A systematic review. 姜黄素对放射性皮炎的疗效:系统综述。
IF 1.9 Q3 CHEMISTRY, MEDICINAL Pub Date : 2024-05-01 DOI: 10.22038/AJP.2023.23175
Hossein Abdeahad, Nikoo Saeedi, Afsane Bahrami, Abdulridha Mohammed Al-Asady, Saeide Mansoori, Amir Avan, Majid Khazaei, Elnaz Ghorbani, Mikhail Ryzhikov, Seyed Mahdi Hassanian

Objective: Radiodermatitis (RD) is a frequent adverse event of radiotherapy (RT). Currently, there is no consensus and approved protocol for the treatment of RD. Curcumin (CUR) is a natural polyphenol obtained from turmeric and it has low intrinsic toxicity in humans. The aim of this systematic review was to explore the efficacy of CUR for prevention and treatment of RD.

Materials and methods: A systematic literature review was performed in the following online databases: Cochrane library, PubMed, Scopus, Web of Science, MEDLINE, and EMBASE. Among the 5 selected records, 3 had a randomized clinical trial (RCT)-design and the other had a pilot and controlled study designed. The included studies were performed on breast cancer (N=3), head and neck cancers (N=1) and different types of cancer (N=1).

Results: Four of the studies reported that the application of curcumin in cancer patients undergoing radiotherapy is associated with decreased intensity of radiodermatitis. However, one study did not report any significant effect of CUR on radiodermatitis. This review provides substantial evidence which confirm the clinical value of CUR in cancer supportive care.

Conclusion: Further prospective clinical trials in larger scales are warranted in order to determine the " supplemental form and dose of CUR" for RD prevention and treatment in patients receiving radiotherapy.

目的:放射性皮炎(RD)是放射治疗(RT)的常见不良反应。目前,治疗放射性皮炎尚无一致认可的方案。姜黄素(CUR)是从姜黄中提取的一种天然多酚,对人体的内在毒性较低。本系统综述旨在探讨姜黄素预防和治疗 RD 的疗效:在以下在线数据库中进行了系统性文献综述:材料:在以下在线数据库中进行了系统文献综述:Cochrane library、PubMed、Scopus、Web of Science、MEDLINE 和 EMBASE。在所选的 5 篇文献中,3 篇采用了随机临床试验(RCT)设计,另一篇采用了试验性对照研究设计。纳入的研究涉及乳腺癌(3 项)、头颈部癌症(1 项)和不同类型的癌症(1 项):结果:其中四项研究报告称,接受放疗的癌症患者服用姜黄素可减轻放射性皮炎的程度。然而,有一项研究并未报告姜黄素对放射性皮炎有任何显著影响。本综述提供了大量证据,证实了姜黄素在癌症辅助治疗中的临床价值:为了确定 "CUR 的补充形式和剂量",以预防和治疗接受放射治疗的患者的放射性皮炎,有必要进行更大规模的前瞻性临床试验。
{"title":"Therapeutic potency of curcumin on radiodermatitis: A systematic review.","authors":"Hossein Abdeahad, Nikoo Saeedi, Afsane Bahrami, Abdulridha Mohammed Al-Asady, Saeide Mansoori, Amir Avan, Majid Khazaei, Elnaz Ghorbani, Mikhail Ryzhikov, Seyed Mahdi Hassanian","doi":"10.22038/AJP.2023.23175","DOIUrl":"10.22038/AJP.2023.23175","url":null,"abstract":"<p><strong>Objective: </strong>Radiodermatitis (RD) is a frequent adverse event of radiotherapy (RT). Currently, there is no consensus and approved protocol for the treatment of RD. Curcumin (CUR) is a natural polyphenol obtained from turmeric and it has low intrinsic toxicity in humans. The aim of this systematic review was to explore the efficacy of CUR for prevention and treatment of RD.</p><p><strong>Materials and methods: </strong>A systematic literature review was performed in the following online databases: Cochrane library, PubMed, Scopus, Web of Science, MEDLINE, and EMBASE. Among the 5 selected records, 3 had a randomized clinical trial (RCT)-design and the other had a pilot and controlled study designed. The included studies were performed on breast cancer (N=3), head and neck cancers (N=1) and different types of cancer (N=1).</p><p><strong>Results: </strong>Four of the studies reported that the application of curcumin in cancer patients undergoing radiotherapy is associated with decreased intensity of radiodermatitis. However, one study did not report any significant effect of CUR on radiodermatitis. This review provides substantial evidence which confirm the clinical value of CUR in cancer supportive care.</p><p><strong>Conclusion: </strong>Further prospective clinical trials in larger scales are warranted in order to determine the \" supplemental form and dose of CUR\" for RD prevention and treatment in patients receiving radiotherapy.</p>","PeriodicalId":8677,"journal":{"name":"Avicenna Journal of Phytomedicine","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11287031/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141858943","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hydrophilic extract of Pistacia vera pericarp protects against phenylhydrazine-induced hepatotoxicity and hemolytic anemia. Pistacia vera果皮的亲水提取物可防止苯肼引起的肝毒性和溶血性贫血。
IF 1.9 Q3 CHEMISTRY, MEDICINAL Pub Date : 2024-05-01 DOI: 10.22038/AJP.2024.23925
Fatemeh Amin, Najmeh Parvaz, Nahid Askari, Morteza Khademalhosseini, Sakineh Khanamani Falahatipour, Iman Fatemi, Fatemeh Khajehasani, Zahra Taghipour, Soudeh Khanamani Falahati-Pour

Objective: Pistacia vera is commonly used in traditional medicine to treat various disorders. This study aims to investigate the anti-anemia and hepatoprotective effects of Pistacia vera pericarp extract (PVPE) in a rat model of phenylhydrazine (PHZ)-induced anemia.

Materials and methods: PVPE was prepared using the maceration method. The extract was administered at doses of 20, 80, and 160 mg/kg for 28 days to normal and PHZ-treated rats. The effects of PVPE were evaluated in terms of changes in biochemical, histological, hematological, and molecular biomarkers in the liver and blood.

Results: Administration of PVPE to the anemic animals significantly restored these deleterious effects on hematological parameters compared to the anemic group. Kupffer cell activation was seen in the liver tissue of the anemic rats. Administration of PVPE mitigated these deleterious effects.

Conclusion: PVPE has potent antioxidant activity and may represent a promising treatment for anemia and liver protection in clinical settings.

目的:Pistacia vera 在传统医学中常用于治疗各种疾病。本研究旨在探讨Pistacia vera果皮提取物(PVPE)在苯肼(PHZ)诱导的大鼠贫血模型中的抗贫血和保肝作用:采用浸渍法制备 PVPE。以 20、80 和 160 毫克/千克的剂量给正常大鼠和 PHZ 处理过的大鼠服用 28 天。根据肝脏和血液中生化、组织学、血液学和分子生物标志物的变化,评估了 PVPE 的效果:结果:与贫血组相比,给贫血动物施用 PVPE 能明显恢复血液学参数的有害影响。贫血大鼠的肝组织中出现了 Kupffer 细胞活化。服用 PVPE 可减轻这些有害影响:结论:PVPE 具有强大的抗氧化活性,可能是临床上治疗贫血和保护肝脏的一种有效方法。
{"title":"Hydrophilic extract of <i>Pistacia vera</i> pericarp protects against phenylhydrazine-induced hepatotoxicity and hemolytic anemia.","authors":"Fatemeh Amin, Najmeh Parvaz, Nahid Askari, Morteza Khademalhosseini, Sakineh Khanamani Falahatipour, Iman Fatemi, Fatemeh Khajehasani, Zahra Taghipour, Soudeh Khanamani Falahati-Pour","doi":"10.22038/AJP.2024.23925","DOIUrl":"10.22038/AJP.2024.23925","url":null,"abstract":"<p><strong>Objective: </strong><i>Pistacia vera</i> is commonly used in traditional medicine to treat various disorders. This study aims to investigate the anti-anemia and hepatoprotective effects of <i>Pistacia vera</i> pericarp extract (PVPE) in a rat model of phenylhydrazine (PHZ)-induced anemia.</p><p><strong>Materials and methods: </strong>PVPE was prepared using the maceration method. The extract was administered at doses of 20, 80, and 160 mg/kg for 28 days to normal and PHZ-treated rats. The effects of PVPE were evaluated in terms of changes in biochemical, histological, hematological, and molecular biomarkers in the liver and blood.</p><p><strong>Results: </strong>Administration of PVPE to the anemic animals significantly restored these deleterious effects on hematological parameters compared to the anemic group. Kupffer cell activation was seen in the liver tissue of the anemic rats. Administration of PVPE mitigated these deleterious effects.</p><p><strong>Conclusion: </strong>PVPE has potent antioxidant activity and may represent a promising treatment for anemia and liver protection in clinical settings.</p>","PeriodicalId":8677,"journal":{"name":"Avicenna Journal of Phytomedicine","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11287025/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141858859","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Investigation of the neuroprotective effect of crocin against electromagnetic field-induced cerebellar damage in male Balb/c mice. 研究巴豆素对电磁场诱发的雄性 Balb/c 小鼠小脑损伤的神经保护作用
IF 1.9 Q3 CHEMISTRY, MEDICINAL Pub Date : 2024-05-01 DOI: 10.22038/AJP.2023.23005
Mehrdad Hajinejad, Abdolreza Narouiepour, Fatemeh Alipour, Alireza Ebrahimzadeh Bideskan

Objective: Mobile devices are sources of electromagnetic fields (EMFs) that cause increasing concern among scientists about human health, especially with the long-term use of mobile phones. With regard to this issue, the potential adverse health effects, particularly on brain function have raised public concern. There is considerable evidence that natural compounds have neuro-protective effects due to their antioxidant and anti-inflammatory properties. Growing evidence suggests that crocin as a natural bioactive compound can be considered a potential therapeutic agent against various neurologic disorders. Therefore, the present study investigated the effects of crocin on the cerebellum after exposure to EMF.

Materials and methods: Twenty-four Male Balb/c mice were divided into control group, EMF group (2100 MHZ), EMF +Crocin group (2100 MHZ+50 mg/kg), and crocin group (50 mg/kg). The animals in the EMF and EMF+Crocin groups were exposed continuously for 30 days to an EMF 120 min/day. After 30 days, cerebellar cortex was evaluated by histomorphometric and immunohistochemical methods.

Results: The results showed that 30 days of exposure to EMF had no significant effect on Purkinje cell size. However, EMF reduced significantly the diameter of astrocytes and increased Glial fibrillary acidic protein (GFAP) expression compared to the controls (p<0.05). Our findings also indicated that crocin treatment could improve the diameter of astrocytes and normalize GFAP expression (p<0.05).

Conclusion: This study concluded that 2100-MHz EMF caused adverse effects on the cerebellum through astrocyte damage and crocin could partially reverse the EMF-related adverse effects.

目的:移动设备是电磁场(EMF)的来源,它引起了科学家对人类健康越来越多的关注,尤其是长期使用移动电话。在这个问题上,潜在的不良健康影响,尤其是对大脑功能的影响,已经引起了公众的关注。有大量证据表明,天然化合物具有抗氧化和抗炎特性,对神经有保护作用。越来越多的证据表明,作为一种天然生物活性化合物,黄花菜苷可被视为一种潜在的治疗各种神经系统疾病的药物。因此,本研究调查了暴露于电磁场后巴豆素对小脑的影响:将 24 只雄性 Balb/c 小鼠分为对照组、EMF 组(2100 MHZ)、EMF + crocin 组(2100 MHZ+50 mg/kg)和 crocin 组(50 mg/kg)。EMF组和EMF+藏霉素组的动物连续30天暴露在每天120分钟的EMF中。30 天后,用组织形态计量学和免疫组化方法对小脑皮质进行评估:结果表明,暴露于电磁场 30 天对 Purkinje 细胞的大小没有显著影响。然而,与对照组相比,电磁场明显减小了星形胶质细胞的直径,并增加了胶质纤维酸性蛋白(GFAP)的表达(pConclusion):本研究得出结论:2100兆赫电磁场通过损伤星形胶质细胞对小脑造成不良影响,而羊角霉素可部分逆转电磁场相关的不良影响。
{"title":"Investigation of the neuroprotective effect of crocin against electromagnetic field-induced cerebellar damage in male Balb/c mice.","authors":"Mehrdad Hajinejad, Abdolreza Narouiepour, Fatemeh Alipour, Alireza Ebrahimzadeh Bideskan","doi":"10.22038/AJP.2023.23005","DOIUrl":"10.22038/AJP.2023.23005","url":null,"abstract":"<p><strong>Objective: </strong>Mobile devices are sources of electromagnetic fields (EMFs) that cause increasing concern among scientists about human health, especially with the long-term use of mobile phones. With regard to this issue, the potential adverse health effects, particularly on brain function have raised public concern. There is considerable evidence that natural compounds have neuro-protective effects due to their antioxidant and anti-inflammatory properties. Growing evidence suggests that crocin as a natural bioactive compound can be considered a potential therapeutic agent against various neurologic disorders. Therefore, the present study investigated the effects of crocin on the cerebellum after exposure to EMF.</p><p><strong>Materials and methods: </strong>Twenty-four Male Balb/c mice were divided into control group, EMF group (2100 MHZ), EMF +Crocin group (2100 MHZ+50 mg/kg), and crocin group (50 mg/kg). The animals in the EMF and EMF+Crocin groups were exposed continuously for 30 days to an EMF 120 min/day. After 30 days, cerebellar cortex was evaluated by histomorphometric and immunohistochemical methods.</p><p><strong>Results: </strong>The results showed that 30 days of exposure to EMF had no significant effect on Purkinje cell size. However, EMF reduced significantly the diameter of astrocytes and increased Glial fibrillary acidic protein (GFAP) expression compared to the controls (p<0.05). Our findings also indicated that crocin treatment could improve the diameter of astrocytes and normalize GFAP expression (p<0.05).</p><p><strong>Conclusion: </strong>This study concluded that 2100-MHz EMF caused adverse effects on the cerebellum through astrocyte damage and crocin could partially reverse the EMF-related adverse effects.</p>","PeriodicalId":8677,"journal":{"name":"Avicenna Journal of Phytomedicine","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11287030/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141858860","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The comparison of the effects of nano-silymarin and silymarin on high-fat diet-induced fatty liver of adult male rats. 纳米水飞蓟素和水飞蓟素对高脂饮食诱发的成年雄性大鼠脂肪肝的影响比较。
IF 1.9 Q3 CHEMISTRY, MEDICINAL Pub Date : 2024-05-01 DOI: 10.22038/AJP.2024.23734
Reza Mohebbati, Mohammad Amin Momeni-Moghaddam, Rokhsareh Asghari, Abbasali Abbasnezhad, Alireza Ebrahim Zadeh Bideskan, Davoud Salarbashi, Nasim Khajavian

Objective: Considering the high prevalence of non-alcoholic fatty liver disease and its complications, this study aims to determine and compare the effect of nano-silymarin and silymarin on non-alcoholic fatty liver in rats.

Materials and methods: Rats were divided into 5 groups: Control, high-fat diet, high-fat diet and atorvastatin, high-fat diet and silymarin, and high-fat diet and nano-silymarin. After 12 weeks, blood samples were taken to measure cholesterol, triglyceride, HDL, LDL, ALT and AST. The animals were killed and the liver tissue was removed to examine the histopathological changes.

Results: Feeding with a high-fat diet caused a significant increase in cholesterol, triglyceride and LDL-C in serum of rats compared to the control. Nano-silymarin and silymarin could significantly reduce serum triglyceride compared to negative group but the reduction of cholesterol, LDL-C, AST and ALT by nano-silymarin was not significant as compared to silymarin. The liver histology evaluation mainly showed that in the group receiving nano-silymarin, a significant decrease in the percentage of fat vacuoles and degree of steatosis was observed compared to the negative group. In the positive group, the percentage of fat vacuoles and the degree of steatosis showed a significant decrease compared to the negative group. Group receiving atorvastatin showed a greater protective effect than silymarin and nano-silymarin.

Conclusion: The use of nano-silymarin similar to silymarin in rats treated with a high-fat diet led to a decrease in the percentage of fat vacuoles and the degree of hepatic steatosis mainly and can be used to prevent non-alcoholic fatty liver disease.

研究目的考虑到非酒精性脂肪肝及其并发症的高发病率,本研究旨在确定并比较纳米水飞蓟素和水飞蓟素对大鼠非酒精性脂肪肝的影响:大鼠分为 5 组:对照组、高脂饮食组、高脂饮食和阿托伐他汀组、高脂饮食和水飞蓟素组、高脂饮食和纳米水飞蓟素组。12 周后,采集血液样本测量胆固醇、甘油三酯、高密度脂蛋白、低密度脂蛋白、谷丙转氨酶和谷草转氨酶。将动物处死,取出肝脏组织检查组织病理学变化:结果:与对照组相比,饲喂高脂肪食物会导致大鼠血清中的胆固醇、甘油三酯和低密度脂蛋白胆固醇显著增加。与阴性组相比,纳米水飞蓟素和水飞蓟素能显著降低血清甘油三酯,但与水飞蓟素相比,纳米水飞蓟素对胆固醇、低密度脂蛋白胆固醇、谷草转氨酶和谷丙转氨酶的降低作用不明显。肝脏组织学评估主要显示,与阴性组相比,接受纳米水飞蓟素治疗组的脂肪空泡百分比和脂肪变性程度明显降低。阳性组的脂肪空泡百分比和脂肪变性程度与阴性组相比有显著下降。与水飞蓟素和纳米水飞蓟素相比,接受阿托伐他汀治疗的组显示出更大的保护作用:结论:纳米水飞蓟素与水飞蓟素相似,在高脂饮食大鼠中使用纳米水飞蓟素主要能降低脂肪空泡的百分比和肝脏脂肪变性的程度,可用于预防非酒精性脂肪肝。
{"title":"The comparison of the effects of nano-silymarin and silymarin on high-fat diet-induced fatty liver of adult male rats.","authors":"Reza Mohebbati, Mohammad Amin Momeni-Moghaddam, Rokhsareh Asghari, Abbasali Abbasnezhad, Alireza Ebrahim Zadeh Bideskan, Davoud Salarbashi, Nasim Khajavian","doi":"10.22038/AJP.2024.23734","DOIUrl":"10.22038/AJP.2024.23734","url":null,"abstract":"<p><strong>Objective: </strong>Considering the high prevalence of non-alcoholic fatty liver disease and its complications, this study aims to determine and compare the effect of nano-silymarin and silymarin on non-alcoholic fatty liver in rats.</p><p><strong>Materials and methods: </strong>Rats were divided into 5 groups: Control, high-fat diet, high-fat diet and atorvastatin, high-fat diet and silymarin, and high-fat diet and nano-silymarin. After 12 weeks, blood samples were taken to measure cholesterol, triglyceride, HDL, LDL, ALT and AST. The animals were killed and the liver tissue was removed to examine the histopathological changes.</p><p><strong>Results: </strong>Feeding with a high-fat diet caused a significant increase in cholesterol, triglyceride and LDL-C in serum of rats compared to the control. Nano-silymarin and silymarin could significantly reduce serum triglyceride compared to negative group but the reduction of cholesterol, LDL-C, AST and ALT by nano-silymarin was not significant as compared to silymarin. The liver histology evaluation mainly showed that in the group receiving nano-silymarin, a significant decrease in the percentage of fat vacuoles and degree of steatosis was observed compared to the negative group. In the positive group, the percentage of fat vacuoles and the degree of steatosis showed a significant decrease compared to the negative group. Group receiving atorvastatin showed a greater protective effect than silymarin and nano-silymarin.</p><p><strong>Conclusion: </strong>The use of nano-silymarin similar to silymarin in rats treated with a high-fat diet led to a decrease in the percentage of fat vacuoles and the degree of hepatic steatosis mainly and can be used to prevent non-alcoholic fatty liver disease.</p>","PeriodicalId":8677,"journal":{"name":"Avicenna Journal of Phytomedicine","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11287026/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141858940","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The efficacy of sumac (Rhus coriaria L.) powder supplementation in biochemical and anthropometric measurements in overweight or obese patients with non-alcoholic fatty liver disease: A double-blind randomized controlled trial. 补充苏木(Rhus coriaria L.)粉对超重或肥胖的非酒精性脂肪肝患者的生化指标和人体测量指标的疗效:双盲随机对照试验。
IF 1.9 Q3 CHEMISTRY, MEDICINAL Pub Date : 2024-05-01 DOI: 10.22038/AJP.2024.23927
Mohsen Mohit, Mohammadali Nejati, Najmeh Hejazi, Shayan Modaresi

Objective: This study aimed to assess the effect of sumac supplement in biochemical and anthropometric measurements in overweight or obese patients with non-alcoholic fatty liver disease.

Materials and methods: In this double-blind randomized controlled trial, 45 NAFLD patients were randomly divided into two groups. The intervention group received sumac capsules (3 g/day) with a balanced diet for 8 weeks, while the placebo group received placebo with a balanced diet. Anthropometric indices, lipid profile, fasting blood glucose, insulin, Homeostatic Model Assessment for Insulin Resistance, aspartate transaminase, alanine aminotransferase, high sensitivity C-reactive protein and malondialdehyde were measured at baseline and at the end of the study.

Results: The results revealed a significant decrease in anthropometric indices (weight (p=0.001), body mass index (p=0.001), waist circumference (p=0.001), body fat mass (p=0.001), body fat percentage (p=0.001), visceral fat score (p=0.001), biochemical levels of total cholesterol (p=0.007), fasting blood sugar (p=0.006), insulin (p=0.004) and HOMA-IR (p=0.002)) after the intervention compared to the baseline. However, no significant difference was observed between the two groups concerning anthropometric and biochemical indices.

Conclusion: In this study, no significant differences were observed between the two groups regarding anthropometric and biochemical indices. Thus, further studies with larger sample sizes are recommended to be conducted on the issue.

研究目的本研究旨在评估苏木补充剂对超重或肥胖的非酒精性脂肪肝患者的生化指标和人体测量指标的影响:在这项双盲随机对照试验中,45名非酒精性脂肪肝患者被随机分为两组。干预组服用苏木胶囊(3 克/天)并搭配均衡饮食,为期 8 周;安慰剂组服用安慰剂并搭配均衡饮食,为期 8 周。在基线和研究结束时测量人体测量指数、血脂概况、空腹血糖、胰岛素、胰岛素抵抗自律模型评估、天门冬氨酸转氨酶、丙氨酸氨基转移酶、高敏C反应蛋白和丙二醛:结果显示,人体测量指数(体重(p=0.001)、体重指数(p=0.001)、腰围(p=0.001)、体脂质量(p=0.001)、体脂百分比(p=0.001)、内脏脂肪评分(p=0.001)、总胆固醇(p=0.007)、空腹血糖(p=0.006)、胰岛素(p=0.004)和 HOMA-IR (p=0.002)的生化水平)。然而,在人体测量和生化指标方面,两组之间没有观察到明显差异:在这项研究中,没有观察到两组之间在人体测量和生化指标方面存在明显差异。因此,建议就此问题开展样本量更大的进一步研究。
{"title":"The efficacy of sumac (<i>Rhus coriaria</i> L.) powder supplementation in biochemical and anthropometric measurements in overweight or obese patients with non-alcoholic fatty liver disease: A double-blind randomized controlled trial.","authors":"Mohsen Mohit, Mohammadali Nejati, Najmeh Hejazi, Shayan Modaresi","doi":"10.22038/AJP.2024.23927","DOIUrl":"10.22038/AJP.2024.23927","url":null,"abstract":"<p><strong>Objective: </strong>This study aimed to assess the effect of sumac supplement in biochemical and anthropometric measurements in overweight or obese patients with non-alcoholic fatty liver disease.</p><p><strong>Materials and methods: </strong>In this double-blind randomized controlled trial, 45 NAFLD patients were randomly divided into two groups. The intervention group received sumac capsules (3 g/day) with a balanced diet for 8 weeks, while the placebo group received placebo with a balanced diet. Anthropometric indices, lipid profile, fasting blood glucose, insulin, Homeostatic Model Assessment for Insulin Resistance, aspartate transaminase, alanine aminotransferase, high sensitivity C-reactive protein and malondialdehyde were measured at baseline and at the end of the study.</p><p><strong>Results: </strong>The results revealed a significant decrease in anthropometric indices (weight (p=0.001), body mass index (p=0.001), waist circumference (p=0.001), body fat mass (p=0.001), body fat percentage (p=0.001), visceral fat score (p=0.001), biochemical levels of total cholesterol (p=0.007), fasting blood sugar (p=0.006), insulin (p=0.004) and HOMA-IR (p=0.002)) after the intervention compared to the baseline. However, no significant difference was observed between the two groups concerning anthropometric and biochemical indices.</p><p><strong>Conclusion: </strong>In this study, no significant differences were observed between the two groups regarding anthropometric and biochemical indices. Thus, further studies with larger sample sizes are recommended to be conducted on the issue.</p>","PeriodicalId":8677,"journal":{"name":"Avicenna Journal of Phytomedicine","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11287034/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141858941","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Quercetin may reduce the risk of developing the symptoms of COVID-19. 槲皮素可降低出现 COVID-19 症状的风险。
IF 1.9 Q3 CHEMISTRY, MEDICINAL Pub Date : 2024-03-01 DOI: 10.22038/AJP.2023.22920
Marjan Ajami, Mohammadjavad Sotoudeheian, Anahita Houshiar-Rad, Mina Esmaili, Fatemeh Naeini, Fatemeh Mohammadi Nasrabadi, Saied Doaei, Ali Milani-Bonab

Objective: Recent evidence reported that some dietary compounds like quercetin and apigenin as the most well-known flavonoids with anti-inflammatory effects may inhibit SARS-CoV-2 main protease. The hypothesis of the promising effects and possible mechanisms of action of quercetin against COVID-19 were assessed in this article.

Materials and methods: Related papers on the inhibitory effects of quercetin against COVID-19 were collected using the following search strategy: "corona or coronavirus or COVID or COVID-19 or viral or virus" AND "nutrient or flavonoid or Quercetin".

Results: The findings indicated that quercetin can be considered an effective agent against COVID-19 because of its SARS-CoV-2 main protease and RNA-dependent RNA polymerase inhibitory effects. In addition, quercetin may attenuate angiotensin-converting enzyme-2 (ACE-2) receptors leading to a reduction of SARS-CoV-2 ability to enter host cells. Moreover, the antiviral, anti-inflammatory, and immunomodulatory activities of quercetin have been frequently reported.

Conclusion: Quercetin may be an effective agent for managing the complications of COVID-19. Further longitudinal human studies are warranted.

目的最近有证据表明,一些膳食化合物,如槲皮素和芹菜素,作为最著名的具有抗炎作用的类黄酮,可能会抑制SARS-CoV-2的主要蛋白酶。本文评估了槲皮素对 COVID-19 的预期效果假设和可能的作用机制:采用以下检索策略收集有关槲皮素对 COVID-19 抑制作用的相关论文:"冠状病毒或冠状病毒或COVID或COVID-19或病毒或病毒 "和 "营养素或类黄酮或槲皮素":结果:研究结果表明,槲皮素具有抑制SARS-CoV-2主要蛋白酶和RNA依赖性RNA聚合酶的作用,因此可被视为抗COVID-19的有效药物。此外,槲皮素还能抑制血管紧张素转换酶-2(ACE-2)受体,从而降低 SARS-CoV-2 进入宿主细胞的能力。此外,槲皮素的抗病毒、抗炎和免疫调节活性也屡有报道:结论:槲皮素可能是控制 COVID-19 并发症的有效药物。结论:槲皮素可能是控制 COVID-19 并发症的有效药物,有必要进行进一步的纵向人体研究。
{"title":"Quercetin may reduce the risk of developing the symptoms of COVID-19.","authors":"Marjan Ajami, Mohammadjavad Sotoudeheian, Anahita Houshiar-Rad, Mina Esmaili, Fatemeh Naeini, Fatemeh Mohammadi Nasrabadi, Saied Doaei, Ali Milani-Bonab","doi":"10.22038/AJP.2023.22920","DOIUrl":"10.22038/AJP.2023.22920","url":null,"abstract":"<p><strong>Objective: </strong>Recent evidence reported that some dietary compounds like quercetin and apigenin as the most well-known flavonoids with anti-inflammatory effects may inhibit SARS-CoV-2 main protease. The hypothesis of the promising effects and possible mechanisms of action of quercetin against COVID-19 were assessed in this article.</p><p><strong>Materials and methods: </strong>Related papers on the inhibitory effects of quercetin against COVID-19 were collected using the following search strategy: \"corona or coronavirus or COVID or COVID-19 or viral or virus\" AND \"nutrient or flavonoid or Quercetin\".</p><p><strong>Results: </strong>The findings indicated that quercetin can be considered an effective agent against COVID-19 because of its SARS-CoV-2 main protease and RNA-dependent RNA polymerase inhibitory effects. In addition, quercetin may attenuate angiotensin-converting enzyme-2 (ACE-2) receptors leading to a reduction of SARS-CoV-2 ability to enter host cells. Moreover, the antiviral, anti-inflammatory, and immunomodulatory activities of quercetin have been frequently reported.</p><p><strong>Conclusion: </strong>Quercetin may be an effective agent for managing the complications of COVID-19. Further longitudinal human studies are warranted.</p>","PeriodicalId":8677,"journal":{"name":"Avicenna Journal of Phytomedicine","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11221767/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141533512","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Avicenna Journal of Phytomedicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1